Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-02-27

FDA Approved: TEMODAR — Original Application (Merck Sharp & Dohme LLC)

View source ↗

Summary

FDA approved TEMODAR (temozolomide) as an original application for the treatment of malignant melanoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Temodar (Temozolomide)

Snippet

ORIG AP for TEMODAR (TEMOZOLOMIDE)